The Kotak Life Sciences Fund aims to deploy capital in early- to growth-stage companies across life sciences, including pharmaceuticals, biotechnology, medical devices and digital health
Kotak AMC CIO said investors should consider market's long-term behaviour and not focus only on strong returns of last four years
Joins other fund houses that have already forayed into AIF space amid growing investor interest
While the rally on Friday of 1,961-points was mostly led by positive global cues amid some buying in Adani group shares, the up move on Monday was triggered by the outcome of Maharashtra polls
The value of India's hospital industry is expected to reach 18.35 trillion rupees by 2027 and is growing at a pace of around 18.24%, according to government data
One takeaway from last year is that most IPOs returned money to the investors, S Ramesh, Managing Director and CEO, Kotak Investment Banking, said
Looking from a medium-to-long term perspective, India is well positioned to deliver growth, both from the economy and equity market point of view
Fund manager Deepak Agrawal has been appointed as the new CIO, debt. Another fund manager, Abhishek Bisen has been elevated to the position of head, fixed income position
The impending US Fed taper programme and strengthening of the dollar leading to possible liquidity pull out from EMs, says CEO
Firm told to cough up Rs 50 lakh for violation of the provisions of Sebi Act, MF Regulations, 1996
With Kotak's entry, the club now has seven members